Clinical trial Recruiting at 1 site Observational Ages 18 and up

Measuring treatment compliance for sleep apnea in heart disease patients

Official title: Patients with Coronary Artery Disease or At High Cardiovascular Risk: Measuring Compliance with Treatment for Obstructive Sleep Apnea Syndrome (OAM or CPAP)

Run by University Hospital, Montpellier · NCT06568159 · Data updated 2026-11-12

This study tests how well heart disease patients with sleep apnea stick to using two different treatments, a CPAP machine and a mouthpiece, to see which one they find easier to use.

More Cardiovascular Diseases trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorUniversity Hospital, Montpellier
Academic / other
Locations1 site (Montpellier)
StatusRecruiting
StartedFebruary 14, 2025
Main results expectedFebruary 14, 2026
Study endsFebruary 15, 2026
Registry record updatedFebruary 18, 2025
Trial IDNCT06568159 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with coronary artery disease or at high cardiovascular risk who have moderate to severe obstructive sleep apnea.

Probably not a fit

Patients with unstable heart failure or severe psychiatric disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the compliance, tolerance, and usability of two treatments for obstructive sleep apnea (OSA) in patients with coronary artery disease or those at high cardiovascular risk. The study compares the standard continuous positive airway pressure (CPAP) therapy with a mandibular advancement device (MAD), which may be better tolerated by patients. Participants will include those with moderate to severe OSA, and the study will evaluate how well they adhere to these treatments. The findings could provide insights into the effectiveness of these therapies in a high-risk population.

Why it matters

Potential benefit: If successful, this study could improve treatment adherence and outcomes for patients with obstructive sleep apnea and coronary artery disease.

How similar studies have gone: Previous studies have shown that alternative treatments like MAD can be effective for patients who struggle with CPAP, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Target population: with coronary artery disease or at very high risk of coronary artery disease:

* Patients with coronary artery disease with or without co-morbidities (smoking, diabetes, hypertension, dyslipidaemia, renal insufficiency, overweight, emerging factors including anxiety-depression, shift workers, etc.).
* Hypertensive patients at high cardiovascular risk (target organ damage such as LVH or albuminuria)
* Diabetic patients at high cardiovascular risk
* Type of heart disease: ischaemic heart disease without clinically significant heart failure (NYHA II, III, IV) For the experimental group (MAD): patients with moderate or severe OSA with intolerance or refusal of CPAP and managed by MAD.

For the control group (CPAP): patients with moderate or severe OSA treated with CPAP.

Exclusion Criteria:

* Patients with heart failure not stabilised according to the investigator (NYHA IV)
* Severe psychiatric disorders
* Pregnant or breast-feeding women
* Opposition to participation after a period of reflection
* Not affiliated to a social security scheme,
* Persons under court protection,
* Persons under guardianship or curatorship
* Person taking part in another study with an exclusion period still in progress
* Inability to follow the patient during the study period.

Where it's running

  • CHU de MONTPELLIER
    Montpellier, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.